[{"EntityCommonStockSharesOutstanding_0_Q2_shares":229174914.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":598000.0,"InterestPaidNet_2_Q2_USD":1820000.0,"PurchaseObligationDueInFifthYear_0_Q2_EUR":15500000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":19700000.0,"Depreciation_2_Q2_USD":891000.0,"Depreciation_1_Q2_USD":448000.0,"ProceedsFromSaleOfShortTermInvestments_2_Q2_USD":20000000.0,"AssetsCurrent_0_Q2_USD":72583000.0,"LongTermDebt_0_Q2_USD":121745000.0,"ProductionRelatedImpairmentsOrCharges_1_Q2_USD":0.0,"ProductionRelatedImpairmentsOrCharges_2_Q2_USD":496000.0,"NotesPayableRelatedPartiesNoncurrent_0_Q2_USD":70024000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-19000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":28020000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":13670000.0,"DirectFinancingLeaseDeferredSellingProfit_0_Q2_USD":1419000.0,"DebtInstrumentUnamortizedDiscount_0_Q2_USD":360000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q2_USD":6881000.0,"ShareBasedCompensation_2_Q2_USD":3313000.0,"Assets_0_Q2_USD":102781000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":1683000.0,"CommonStockSharesIssued_0_Q2_shares":228927505.0,"RestrictedCashCurrent_0_Q2_USD":316000.0,"ForeignCurrencyTransactionGainLossRealized_1_Q2_USD":-1867000.0,"PurchaseObligationDueInFourthYear_0_Q2_EUR":14600000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":32845926.0,"AccountsReceivableGrossCurrent_0_Q2_USD":6738000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":3677000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":7841000.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":4873000.0,"ForeignCurrencyTransactionGainLossRealized_2_Q2_USD":-71000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":14706000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":213880000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":28519000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":1464000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":3219000.0,"LiabilityForUncertainTaxPositionsNoncurrent_0_Q2_USD":0.0,"InterestPayableCurrent_0_Q2_USD":410000.0,"CommonStockValue_0_Q2_USD":2289000.0,"UnamortizedDebtIssuanceExpense_0_Q2_USD":450000.0,"PurchaseObligationDueInNextTwelveMonths_0_Q2_EUR":6600000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":14000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":10000.0,"ProceedsFromStockPlans_2_Q2_USD":14000.0,"PurchaseObligationDueInSecondYear_0_Q2_EUR":8500000.0,"ShortTermInvestments_0_Q2_USD":0.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-3803000.0,"AccountsReceivableNetCurrent_0_Q2_USD":3366000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CostsAndExpenses_2_Q2_USD":46385000.0,"FinancialLiabilitiesFairValueDisclosure_0_Q2_USD":118200000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":212943000.0,"DepreciationAndAmortization_2_Q2_USD":1105000.0,"ConvertibleLongTermNotesPayable_0_Q2_USD":5000000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q2_USD":83940000.0,"Liabilities_0_Q2_USD":282491000.0,"CostsAndExpenses_1_Q2_USD":23029000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":2829478000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":63222000.0,"OtherAssetsNoncurrent_0_Q2_USD":4011000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1032000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-10252000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-19593000.0,"IncreaseDecreaseInInventories_2_Q2_USD":164000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1843000.0,"DebtInstrumentFaceAmount_0_Q2_USD":122600000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-1352000.0,"CommonStockSharesAuthorized_0_Q2_shares":400000000.0,"NonoperatingIncomeExpense_2_Q2_USD":-4538000.0,"AccountsPayableCurrent_0_Q2_USD":5821000.0,"LiabilitiesCurrent_0_Q2_USD":67939000.0,"ProceedsFromWarrantExercises_2_Q2_USD":11600000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":1542000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-14903000.0,"NonoperatingIncomeExpense_1_Q2_USD":-2337000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2185000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-19574000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q2_USD":4255000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":96168000.0,"AmortizationOfFinancingCosts_1_Q2_USD":27000.0,"AmortizationOfFinancingCosts_2_Q2_USD":55000.0,"CommonStockSharesOutstanding_0_Q2_shares":228927505.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-10252000.0,"AssetImpairmentCharges_1_Q2_USD":368000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":1856000.0,"InterestExpenseDebt_2_Q2_USD":2155000.0,"NetIncomeLoss_1_Q2_USD":-10252000.0,"NetIncomeLoss_2_Q2_USD":-19574000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":26187000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":14146000.0,"OperatingLeasePayments_1_Q2_USD":400000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":594000.0,"OperatingLeasePayments_2_Q2_USD":900000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":63538000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q2_USD":320000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-82000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.075,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2_Q2_USD":-19000.0,"InterestExpenseDebt_1_Q2_USD":1084000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":391000.0,"AssetImpairmentCharges_2_Q2_USD":1889000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":33316000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":6715000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":102781000.0,"OperatingLeaseCost_1_Q2_USD":400000.0,"OperatingLeaseCost_2_Q2_USD":700000.0,"PreferredStockValue_0_Q2_USD":null,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":32184000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"InvestmentIncomeInterest_1_Q2_USD":14000.0,"InventoryNet_0_Q2_USD":3823000.0,"NotesPayableCurrent_0_Q2_USD":5387000.0,"OperatingIncomeLoss_1_Q2_USD":-7915000.0,"OperatingIncomeLoss_2_Q2_USD":-15036000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":15114000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":31349000.0,"InvestmentIncomeInterest_2_Q2_USD":147000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-147000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":13333000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2185000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-3011477000.0,"VariableLeaseCost_1_Q2_USD":100000.0,"VariableLeaseCost_2_Q2_USD":200000.0,"LongTermInvestments_0_Q2_USD":0.0,"DebtInstrumentCarryingAmount_0_Q2_USD":122555000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":300000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":3313000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":4860000.0,"StockholdersEquity_0_Q2_USD":-179710000.0,"ProfitLoss_2_Q2_USD":-19574000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.05,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.09,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-1343000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":122355000.0,"PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_EUR":5500000.0,"PurchaseObligationDueInThirdYear_0_Q2_EUR":10800000.0,"Ticker":"MNKD","CIK":"899460","name":"MANNKIND CORP","OfficialName":"MannKind Corporation Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"shares","footnote":"nan","Market Cap":"898029416.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200805"}]